[1]
Paris, D.; Maniscalco, M.; Melck, D.; D’amato, M.; Sofia, M.; Motta, A. Metabolites in exhaled breath condensate characterize the obese respiratory phenotype. Metabolomics, 2015, 11(4), 1934-1939.
[2]
Maniscalco, M.; Faraone, S.; Sofia, M.; Molino, A.; Vatrella, A.; Zedda, A. Extended analysis of exhaled and nasal nitric oxide for the evaluation of chronic cough. Respir. Med., 2015, 109(8), 970-974.
[3]
Motta, A.; Paris, D.; D’amato, M.; Melck, D.; Calabrese, C.; Vitale, C.; Stanziola, A.A.; Corso, G.; Sofia, M.; Maniscalco, M. NMR metabolomic analysis of exhaled breath condensate of asthmatic patients at two different temperatures. J. Proteome Res., 2014, 13(12), 6107-6120.
[4]
De Laurentiis, G.; Paris, D.; Melck, D.; Montuschi, P.; Maniscalco, M.; Bianco, A.; Sofia, M.; Motta, A. Separating smoking-related diseases using NMR-based metabolomics of exhaled breath condensate. J. Proteome Res., 2013, 12(3), 1502-1511.
[5]
Motta, A.; Paris, D.; Melck, D.; De Laurentiis, G.; Maniscalco, M.; Sofia, M.; Montuschi, P. Nuclear magnetic resonance-based metabolomics of exhaled breath condensate: methodological aspects. Eur. Respir. J., 2012, 39(2), 498-500.
[6]
De Laurentiis, G.; Paris, D.; Melck, D.; Maniscalco, M. Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy. Eur. Respir. J., 2008, 32(5), 1175-1183.
Related Journals
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Current Probiotics
Article Metrics
20
4
3
3